Fig. 7
From: Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway
Changes of OS parameters in the Hip and mPFC after EDA exposure. A–E Levels of OS parameters including MDA, SOD,GSH,GSH-PX and T-AOC in the Hip. F–J MDA content, the activities of SOD, GSH, GSH-PX and T-AOC in the mPFC. Data are presented as mean ± SEM (n = 6 per group). *p < 0.05, **p < 0.01, ***p < 0.001 versus the CON + Vehicle group. #p < 0.05, ##p < 0.01, ###p < 0.001 versus the CSDS + Vehicle group